Adam A. Capoferri

3.5k total citations · 2 hit papers
24 papers, 1.7k citations indexed

About

Adam A. Capoferri is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Adam A. Capoferri has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 17 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Adam A. Capoferri's work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (9 papers). Adam A. Capoferri is often cited by papers focused on HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (9 papers). Adam A. Capoferri collaborates with scholars based in United States, Uganda and Canada. Adam A. Capoferri's co-authors include Robert F. Siliciano, Janet D. Siliciano, Ya‐Chi Ho, Katherine M. Bruner, Ross A. Pollack, Nina N. Hosmane, Subul Beg, Kyungyoon J. Kwon, Jun Lai and Rebecca Hoh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Adam A. Capoferri

23 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defective proviruses rapidly accumulate during acute HIV-1 infection

2016 515 citations Katherine M. Bruner, Alexandra J. Murray et al. Nature Medicine profile →
Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape

2017 254 citations Ross A. Pollack, R. Brad Jones et al. Cell Host & Microbe profile →

Peers

Countries citing papers authored by Adam A. Capoferri

Since Specialization

Citations

This map shows the geographic impact of Adam A. Capoferri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam A. Capoferri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam A. Capoferri more than expected).

Fields of papers citing papers by Adam A. Capoferri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam A. Capoferri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam A. Capoferri. The network helps show where Adam A. Capoferri may publish in the future.

Co-authorship network of co-authors of Adam A. Capoferri

This figure shows the co-authorship network connecting the top 25 collaborators of Adam A. Capoferri. A scholar is included among the top collaborators of Adam A. Capoferri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam A. Capoferri. Adam A. Capoferri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Divergent populations of HIV-infected naive and memory CD4+ T cell clones in children on antiretroviral therapy 2025 ·Journal of Clinical Investigation ·(unknown), (unknown), Shuang Guo, Sean C. Patro, (unknown), Brian T. Luke, Adam A. Capoferri, Xiaolin Wu, (unknown), Jason W. Rausch, Ann Chahroudi, Maud Mavigner, Mary F. Kearney	1
2	In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individuals 2025 ·Life Science Alliance ·Adam A. Capoferri, (unknown), (unknown), (unknown), Rui Li, Jason W. Rausch, Brian T. Luke, Rebecca Hoh, Steven G. Deeks, John W. Mellors, John M. Coffin, Jennifer L. Groebner, Fabio Romerio, Mary F. Kearney	2
3	HIV Expression in Infected T Cell Clones 2024 ·Viruses ·Jason W. Rausch, (unknown), (unknown), Adam A. Capoferri, Mary F. Kearney	5
4	HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA 2024 ·Proceedings of the National Academy of Sciences ·Adam A. Capoferri, Ann Wiegand, Feiyu Hong, Jana L. Jacobs, Jonathan Spindler, Andrew Musick, Michael J. Bale, Wei Shao, Michele D. Sobolewski, Anthony R. Cillo, Brian T. Luke, Christine M. Fennessey, Robert J. Gorelick, Rebecca Hoh, Elias K. Halvas, Steven G. Deeks, John M. Coffin, John W. Mellors, Mary F. Kearney	3
5	Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda 2020 ·JCI Insight ·Jessica L. Prodger, Adam A. Capoferri, Katherine Yu, Jun Lai, Steven J. Reynolds, (unknown), (unknown), (unknown), David Serwadda, Kyungyoon J. Kwon, (unknown), Craig Martens, Eileen P. Scully, Yun‐Hee Choi, Andrew D. Redd, Thomas C. Quinn	24
6	Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial) 2020 ·Blood ·Juan Carlos Ramos, Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, P Rubinstein, Christine M. Durand, Ethel Cesarman, David M. Aboulafia, Robert A. Baiocchi, Lee Ratner, Lawrence Kaplan, Adam A. Capoferri, Jeannette Y. Lee, Ronald T. Mitsuyasu, Ariela Noy	36
7	Haemopoietic cell transplantation in patients living with HIV 2020 ·The Lancet HIV ·Richard F. Ambinder, Adam A. Capoferri, Christine M. Durand	15
8	HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus 2019 ·Frontiers in Microbiology ·Andrew Musick, Jonathan Spindler, Eli Boritz, Liliana Pérez, (unknown), Sean C. Patro, Michele D. Sobolewski, Michael J. Bale, Carolyn Reid, Brandon F. Keele, Adam A. Capoferri, Wei Shao, Ann Wiegand, Francesco R. Simonetti, John W. Mellors, Stephen H. Hughes, John M. Coffin, Frank Maldarelli, Mary F. Kearney	44
9	Phylogenetic inference for the study of within-host HIV-1 dynamics and persistence on antiretroviral therapy 2019 ·The Lancet HIV ·Adam A. Capoferri, Michael J. Bale, Francesco R. Simonetti, Mary F. Kearney	9
10	Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays 2018 ·Retrovirology ·Art F. Y. Poon, Jessica L. Prodger, (unknown), Jun Lai, Steven J. Reynolds, (unknown), Adam A. Capoferri, Susanna L. Lamers, (unknown), Daniel Bruno, Stephen F. Porcella, Craig Martens, Thomas C. Quinn, Andrew D. Redd	5
11	Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses 2018 ·PLoS ONE ·Christopher W. Pohlmeyer, Sarah B. Laskey, Sarah E. Beck, (unknown), Adam A. Capoferri, Caroline C. Garliss, (unknown), (unknown), (unknown), Richard D. Moore, Mary S. Leffell, Nicholas J. Butler, Jennifer E. Thorne, John A. Flynn, Robert F. Siliciano, Joel N. Blankson	8
12	Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane 2018 ·Proceedings of the National Academy of Sciences ·Zheng Wang, (unknown), Timothy Brennan, Jeffrey M. Gerold, Kyungyoon J. Kwon, Nina N. Hosmane, Mithra R. Kumar, Subul Beg, Adam A. Capoferri, Stuart C. Ray, Ya‐Chi Ho, Alison L. Hill, Janet D. Siliciano, Robert F. Siliciano	157
13	Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape breakdown → 2017 ·Cell Host & Microbe ·Ross A. Pollack, R. Brad Jones, Mihaela Pertea, Katherine M. Bruner, Alyssa R. Martin, Allison S. Thomas, Adam A. Capoferri, Subul Beg, Szu-Han Huang, Sara Karandish, Haiping Hao, Eitan Halper‐Stromberg, (unknown), Colin Kovacs, Erika Benko, Robert F. Siliciano, Ya‐Chi Ho	254
14	Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4+ T Cells Permissive for Latent HIV-1 Infection 2017 ·Immunity ·Liang Shan, Kai Deng, Hongbo Gao, Sifei Xing, Adam A. Capoferri, Christine M. Durand, S. Alireza Rabi, Gregory M. Laird, Michelle Kim, Nina N. Hosmane, Hung‐Chih Yang, Hao Zhang, Joseph B. Margolick, Linghua Li, Weiping Cai, Ruian Ke, Richard A. Flavell, Janet D. Siliciano, Robert F. Siliciano	132
15	Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics 2017 ·The Journal of Experimental Medicine ·Nina N. Hosmane, Kyungyoon J. Kwon, Katherine M. Bruner, Adam A. Capoferri, Subul Beg, Daniel I. S. Rosenbloom, Brandon F. Keele, Ya‐Chi Ho, Janet D. Siliciano, Robert F. Siliciano	274
16	Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda 2017 ·Clinical Infectious Diseases ·Jessica L. Prodger, Jun Lai, Steven J. Reynolds, Jeanne Keruly, Richard D. Moore, (unknown), (unknown), (unknown), David Serwadda, Martha Nason, Adam A. Capoferri, Stephen F. Porcella, Robert F. Siliciano, Andrew D. Redd, Janet D. Siliciano, Thomas C. Quinn	17
17	Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity 2017 ·Journal of Clinical Investigation ·Alyssa R. Martin, Ross A. Pollack, Adam A. Capoferri, Richard F. Ambinder, Christine M. Durand, Robert F. Siliciano	54
18	Defective proviruses rapidly accumulate during acute HIV-1 infection breakdown → 2016 ·Nature Medicine ·Katherine M. Bruner, Alexandra J. Murray, Ross A. Pollack, Mary Soliman, Sarah B. Laskey, Adam A. Capoferri, Jun Lai, Matthew C. Strain, Steven M. Lada, Rebecca Hoh, Ya‐Chi Ho, Douglas D. Richman, Steven G. Deeks, Janet D. Siliciano, Robert F. Siliciano	515
19	Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells 2016 ·eLife ·Erik C Hansen, Monica Ransom, Jay R. Hesselberth, Nina N. Hosmane, Adam A. Capoferri, Katherine M. Bruner, Ross A. Pollack, Hao Zhang, Michael Drummond, Janet D. Siliciano, Robert F. Siliciano, James T. Stivers	36
20	A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence 2014 ·Nature Protocols ·Michelle Kim, Nina N. Hosmane, C. Korin Bullen, Adam A. Capoferri, Hung‐Chih Yang, Janet D. Siliciano, Robert F. Siliciano	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact